A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia Interventions: Drug: abaloparatide; Drug: bevacizumab Sponsor: University of Rochester Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials